CL
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Identification of individuals at high risk of developing rheumatoid arthritis : a balanced random forest model in a cohort of 1544 first-degree relatives | RMD open |  | 2025 | 7 | 22 | ||
| Anti-Apolipoprotein A-1 IgG, incident cardiovascular events and lipid paradox inrheumatoid arthritis | ESC (Europan Society of Cardiology) Congress 2024 | 2024 | 4 | 0 | |||
| Gut microbiome and intestinal inflammation in preclinical stages of rheumatoid arthritis | RMD open | | 2024 | 105 | 62 | ||
| Anti-apolipoprotein A-1 IgG, incident cardiovascular events and lipid paradox in rheumatoid arthritis | 92nd EAS (European Atherosclerosis Society) Congress | 2024 | 7 | 0 | |||
| Anti-apolipoprotein A-1 IgG, incident cardiovascular events, and lipid paradox in rheumatoid arthritis | Frontiers in cardiovascular medicine | | 2024 | 114 | 150 | ||
| Brief report: can COVID-19 infection trigger rheumatoid arthritis-associated autoimmunity in individuals at risk for the disease? A nested cohort study | Frontiers in medicine | | 2023 | 67 | 83 | ||
| A potential role for chlamydial infection in rheumatoid arthritis development | Rheumatology | | 2023 | 91 | 165 | ||
| Brief report : assessment of mucosal barrier integrity using serological biomarkers in preclinical stages of rheumatoid arthritis | Frontiers in immunology | | 2023 | 184 | 210 | ||
| Impact of SARS-CoV2 infection on anti-apolipoprotein A-1 IgG response in inflammatory rheumatic diseases | Frontiers in immunology | | 2023 | 130 | 81 | ||
| Peut-on prédire la polyarthrite rhumatoïde ? | Revue du rhumatisme monographies |  | 2022 | 117 | 0 | ||
| Comparative Genetic Analysis of Psoriatic Arthritis and Psoriasis for the Discovery of Genetic Risk Factors and Risk Prediction Modeling | Arthritis & rheumatology | | 2022 | 131 | 102 | ||
| Predictive value of anti-CarP and anti-PAD3 antibodies alone or in combination with RF and ACPA on the severity of rheumatoid arthritis | Rheumatology | | 2021 | 378 | 450 | ||
| Cohort profile: SCREEN-RA: design, methods and perspectives of a Swiss cohort study of first-degree relatives of patients with rheumatoid arthritis | BMJ Open | | 2021 | 354 | 153 | ||
| Identification of biological pathways specific to phases preceding rheumatoid arthritis development through gene expression profiling | International Journal of Immunogenetics | | 2021 | 215 | 0 | ||
| Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis | Arthritis Research and Therapy | | 2020 | 413 | 328 | ||
| Measuring ACPA in the general population or primary care: is it useful? | RMD Open | | 2020 | 239 | 171 | ||
| Detection of circulating highly expanded T-cell clones in at-risk individuals for rheumatoid arthritis before the clinical onset of the disease | Rheumatology | | 2020 | 324 | 8 | ||
| Prevotella copri in individuals at risk for rheumatoid arthritis | Annals of the Rheumatic Diseases | 2019 | 466 | 0 | |||
| Comparison of Serological Biomarkers in Rheumatoid Arthritis and Their Combination to Improve Diagnostic Performance | Frontiers in Immunology | | 2018 | 425 | 302 | ||
| Female hormonal factors and the development of anti-citrullinated protein antibodies in women at risk of rheumatoid arthritis | Rheumatology | | 2017 | 550 | 5 | ||
| The prevalence of anticitrullinated protein antibodies increases with age in healthy individuals at risk for rheumatoid arthritis | Clinical Rheumatology | | 2017 | 629 | 3 | ||
| Immune-mediated experimental arthritis in IL-33 deficient mice | Cytokine | | 2014 | 675 | 0 | ||
| The severity of experimental arthritis is independent of IL-36 receptor signaling | Arthritis research & therapy | | 2013 | 630 | 248 | ||
| Mouse neutrophils express the decoy type 2 interleukin-1 receptor (IL-1R2) constitutively and in acute inflammatory conditions | Journal of leukocyte biology | | 2013 | 549 | 542 | ||
| Disease severity in K/BxN serum transfer-induced arthritis is not affected by IL-33 deficiency | Arthritis research & therapy | | 2013 | 645 | 281 | ||
| Endogenous IL-1α is a chromatin-associated protein in mouse macrophages | Cytokine | | 2013 | 636 | 1 | ||
| Long-term amelioration of established collagen-induced arthritis achieved with short-term therapy combining anti-CD3 and anti-tumor necrosis factor treatments | Arthritis and rheumatism | | 2012 | 622 | 1 | ||
| Mice deficient in hepatocyte-specific IL-1Ra show delayed resolution of concanavalin A-induced hepatitis | European Journal of Immunology | | 2012 | 623 | 3 | ||
| The mouse interleukin (Il)33 gene is expressed in a cell type- and stimulus-dependent manner from two alternative promoters | Journal of leukocyte biology |  | 2012 | 712 | 0 | ||
| IL-36 signaling amplifies Th1 responses by enhancing proliferation and Th1 polarization of naive CD4+ T cells | Blood | | 2012 | 879 | 1,029 | ||
| Articular inflammation is controlled by myeloid cell-derived interleukin 1 receptor antagonist during the acute phase of arthritis in mice | Annals of the rheumatic diseases | | 2012 | 674 | 0 | ||
| IL-36R ligands are potent regulators of dendritic and T cells | Blood | | 2011 | 660 | 0 | ||
| Autoimmunity and inflammation are independent of class II transactivator type PIV-dependent class II major histocompatibility complex expression in peripheral tissues during collagen-induced arthritis | Arthritis and rheumatism | | 2011 | 645 | 0 | ||
| Distinct roles of hepatocyte- and myeloid cell-derived IL-1 receptor antagonist during endotoxemia and sterile inflammation in mice | The Journal of immunology | | 2010 | 565 | 0 | ||
| Enhanced Th1 and Th17 responses and arthritis severity in mice with a deficiency of myeloid cell-specific interleukin-1 receptor antagonist | Arthritis and rheumatism | | 2010 | 619 | 0 | ||
| IL-1 pathways in inflammation and human diseases | Nature reviews. Rheumatology | | 2010 | 742 | 1 | ||
| Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis | Arthritis and rheumatism | | 2009 | 658 | 0 | ||
| Production and functional role of Interleukin-1 receptor antagonist in immune and inflammatory responses in vivo | | 2009 | 1,126 | 1,085 | |||
| Interleukin-33 is biologically active independently of caspase-1 cleavage | The Journal of biological chemistry | | 2009 | 682 | 512 |
